Biocastanea

Biocastanea upcycles chestnut burr waste into certified eco‐cosmeceuticals via green extraction of antioxidants. Biocastanea promotes zero‐waste valorisation and scalable bioeconomy.

Biocastanea is a line of eco-sustainable dermofunctional biocosmeceuticals made from chestnut burr extract. This line is developed by the women-led start-up SienabioACTIVE, Siena University bioeconomy spin-off, holding international organic certification.

Chestnut burrs are usually burned, emitting CO₂. Biocastanea transforms this bio-waste into a valuable resource through an advanced bioeconomy research project, combining pharma academic excellence and local resources in a local value chain, ensuring quality, sustainability, and impact.

The Biocastanea team optimised green methods to extract antioxidants from the Protected Geographical Indication (PGI) Monte Amiata chestnut burr, which possesses potent antioxidant, anti-inflammatory, and antimicrobial properties (Patent). Biocastanea products are available in physical stores and on e-commerce sites. SienabioACTIVE’s commitment to zero-waste led to transforming residual burr biomass obtained from the process into paper and bioplastics, currently at TRL7.

Biocastanea’s prototype was achieved thanks to a Tuscany Rural Development Programme (RDP) grant of approximately €300,000. Rural Development Programmes (RDPs), like European Regional Development Funds (ERDF), are useful tools for initial stages, but present limitations in terms of scope, applicability and functioning to support the market uptake of the funded innovations.

The Biocastanea line is currently available in the local market, and the strategy is to scale it up at the regional and EU levels by establishing partnerships to implement a pilot plant, which will incorporate Biocastanea and other innovations. Amongst these, the patent developed on the chestnut burr extract’s bioactivity that lowers antibiotics posology managing antimicrobial resistance (Inpart Top 25 Innovations 2025). To scale up, the team is working to overcome the main challenges related to an often-inadequate EU funding/venture capital ecosystem and a regulatory framework for pharma and bioeconomy that is complex and sometimes contradictory.

Resources

Contact information

Annalisa Santucci

Full Professor of Biochemistry, Università Degli Studi Di Siena

Learn more

Forestry Hub of Catalonia
The Forestry Hub of Catalonia is an initiative supporting innovation in forestry value chains. Its facilities for research, development, transfer, facilitation and training.
Bio Base Europe Pilot Plant
The Bio Base Europe Pilot Plant (BBEPP) is a leading open-access facility supporting the scale-up of bio-based innovations from lab to industrial scale.
CMPC Venture Client
CMPC Ventures’ Venture Client supports start-ups through partnerships, pilots, and direct investment. Launched in 2024, the CMPC has completed 15 pilots, including two forestry-focused projects.
Circular Bio-based Europe Joint Undertaking
The Circular Bio-based Europe Joint Undertaking (CBE JU) is a key promoter of sustainable growth and competitiveness in Europe.
European Circular Bioeconomy Fund
ECBF is the first private venture capital fund exclusively dedicated to investing in growth-stage companies within the European bioeconomy.
Strong by Form
Strong by Form develops Woodflow, a biomimetic, digitally-designed timber composite replacing steel, concrete, plastics via strategic partnerships, phased financing, deep-tech planning.
Biocon
Biocon’s reductive catalytic fractionation transforms lignocellulose into lignin oil, pulp, and sugars at pilot scale.
Green Angel Ventures Limited
With a strong track record, GAV shares lessons on avoiding the “Valley of Death” and supporting start-ups to scale successfully.
PhotonHub & EIC Scaling Club
PhotonHub Europe and the EIC Scaling Club provide approaches to help the commercialisation of technologies across various sectors.
Workshop: Scaling up forest-based innovations in Europe
Read the cases presented at the Workshop: Scaling up forest-based innovations in Europe on 15 May 2025 in Brussels, Belgium.